The use of recombinant DNA technology for the development of a bluetongue virus subunit vaccine

Show simple item record

dc.contributor.editor Bigalke, R.D.
dc.contributor.upauthor Huismans, H. (Henk), 1942-
dc.date.accessioned 2015-04-14T09:14:57Z
dc.date.available 2015-04-14T09:14:57Z
dc.date.created 2014
dc.date.issued 1985
dc.description The articles have been scanned in colour with a HP Scanjet 5590; 600dpi. Adobe Acrobat XI Pro was used to OCR the text and also for the merging and conversion to the final presentation PDF-format. en_ZA
dc.description.abstract The double-stranded RNA gene coding for the surface antigen responsible for inducing neutralising antibodies has been isolated, converted to DNA, and cloned in the plasmid pBR322. So far, only plasmids containing inserts smaller than the gene have been obtained. Possible strategies for the development of a bluetongue virus subunit vaccine are discussed. en_ZA
dc.identifier.citation Huismans, H 1985, 'The use of recombinant DNA technology for the development of a bluetongue virus subunit vaccine’, Onderstepoort Journal of Veterinary Research, vol. 52, no. 3, pp. 149-151. en_ZA
dc.identifier.issn 0330-2465
dc.identifier.uri http://hdl.handle.net/2263/44388
dc.language.iso en en_ZA
dc.publisher Published by The Government Printer, Pretoria en_ZA
dc.rights ©ARC - Onderstepoort and Faculty of Veterinary Science, University of Pretoria (original). ©University of Pretoria. Dept. of Library Services (digital). en_ZA
dc.subject Veterinary medicine en_ZA
dc.subject.lcsh Veterinary medicine -- South Africa
dc.title The use of recombinant DNA technology for the development of a bluetongue virus subunit vaccine en_ZA
dc.type Article en_ZA


Files in this item

This item appears in the following Collection(s)

Show simple item record